Docket Room
A9156A·NY·house

Prohibits the sale of 7-hydroxymitragynine products

Floor Vote ScheduledFiled Oct 17, 2025
Sponsor: Phil Steck
Latest Action

SUBSTITUTED BY S8925A

Jun 3, 2026

Summary

The bill adds a new section to the General Business Law that makes it illegal for any business in New York to sell, offer, or deliver products with more than 2% of total alkaloids or one milligram per serving of 7‑hydroxymitragynine. Violations carry a civil penalty of up to $3,000 for a first offense and $650 for each subsequent offense, with the money placed in a state drug‑treatment and education fund. The measure aims to curb the distribution of a potent opioid derivative that poses public‑health risks.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when A9156A changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice